CMM Spotlight Series: Dr Bethan Lloyd-Lewis 28 June 2021 As part of our CMM Spotlight Series, PhD students' Drinalda Cela and Michaela Gregorova interview Dr Bethan Lloyd-Lewis - a Vice Chancellor's Fellow in CMM. Her research is focused on examining the biological mechanisms that regulate epithelial cell fate during tissue development and the early stages of cancer, with a particular interest in breast biology. The aim of her research is ultimately to define improved approaches for breast cancer prevention and early detection, in addition to informing the development of new chemo-preventative and therapeutic strategies.
- CMM Spotlight Series: Dr Bethan Lloyd-Lewis 28 June 2021 As part of our CMM Spotlight Series, PhD students' Drinalda Cela and Michaela Gregorova interview Dr Bethan Lloyd-Lewis - a Vice Chancellor's Fellow in CMM. Her research is focused on examining the biological mechanisms that regulate epithelial cell fate during tissue development and the early stages of cancer, with a particular interest in breast biology. The aim of her research is ultimately to define improved approaches for breast cancer prevention and early detection, in addition to informing the development of new chemo-preventative and therapeutic strategies.
- Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy 24 June 2021 An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.
- GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic 17 June 2021 The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘One Health’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security.
- Young infants produce strong immune response to SARS-CoV-2, study finds 11 June 2021 Young infants show strong immune responses to SARS-CoV-2, new research has found. In particular, compared with adults, young infants produce relatively high levels of antibodies and immune cells that can specifically protect against COVID-19.
- Careers in academia: the LGBTQ+ perspective. 23 April 2021 Lesbian, gay, bisexual, trans and queer (LGBTQ+) people have often not been well represented in STEM careers. Academia should be an environment where sexuality and gender identity does not matter. Nevertheless, some LGBTQ+ scientists have faced discrimination. Last year, the Wellcome Trust commissioned Shift Learning to investigate research cultures*. The survey of over 4000 researchers revealed culture report 24% of respondents would not feel comfortable discussing LGBTQ+ identity discrimination in the workplace. Furthermore, 25% of LGBTQ+ participants who had experienced discrimination or harassment said this was due to sexuality. Therefore, often individuals in the LGBTQ+ community have opted to suppress their gender identity and sexual orientation, which is likely to negatively affect productivity and mental health. Sadly, LGBTQ+ individuals are also five times more likely to commit suicide (The TREVOR Project)**.
- Researchers in CMM and the university continue the fight to eradicate deadly disease on World Tuberculosis Day 25 March 2021 Researchers at the University of Bristol are working on a number of different developments to finally end the TB epidemic.
- CMM has been at the forefront of COVID-19 research 24 March 2021 As the COVID-19 pandemic hit the world, academics from across the School of Cellular and Molecular Medicine and the University of Bristol joined together to understand the virus and the impact of the pandemic. Today [23 March] is a year since the first UK lockdown and their research is continuing to play a key role in global efforts to overcome the disease.
- Using sound to shape the future of printing 16 March 2021 Researchers have developed a way to coax microscopic particles and droplets into precise patterns by harnessing the power of sound in air. The implications for printing, especially in the fields of medicine and electronics, are far-reaching.
- High fructose diets could cause immune system damage 22 February 2021 New research led by Swansea University in collaboration with researchers at the University of Bristol and the Francis Crick Institute in London has indicated that consuming a diet high in the sugar fructose might prevent the proper functioning of peoples' immune systems in ways that has, until now, largely been unknown.
- Eugenia Piddini: Celebrating International Day of Women and Girls in Science 10 February 2021 Drinalda Cela, a PhD student in CMM, interviewed Professor Eugenia Piddini in celebration of the UN International Day of Women and Girls in Science, exploring her research, the critical role of women in STEM and her own experience as a first-generation academic.